Feasibility Trial of a Stakeholder-enhanced Lay-navigator-delivered Intervention (ImPart-Multi)

Kidney Diseases Clinical Trial

— ImPart-Multi  

Official title:

A Feasibility Trial of a Stakeholder-Enhanced, Lay-Navigator-Delivered Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06067009
• Other study ID #: 300011311
• Secondary ID: UAB
• Status: Recruiting
• Phase: N/A
• Start date: March 20, 2024
• Est. completion date: November 15, 2024

Study information

• Verified date: April 2024
• Source: University of Alabama at Birmingham
• Contact: Shena Gazaway, Phd, RN
• Phone: 2059755304
• Email: gazaways[@]uab.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

We seek to explore the feasibility and acceptability of participation in a decision-support training program led by lay navigators. ImPart-Multi, an education-telehealth-based, is designed to empower Black chronic kidney disease patients (CKD) patients and their care partner to seek the resources and support needed to be activated allies when making health-related decisions.

Participants, based on random assignment, will participate in survey completion at study start and at 12 and 24 weeks of enrollment, and will complete 1, 3, or 4 education sessions via telehealth or audio connection. Participants will also complete an interview to share their thoughts on the program and other factors of interest.

Description:

Black people with chronic kidney disease and uncontrolled high blood pressure face a higher risk of developing severe cardiovascular disease and face an additional risk of their kidney disease getting worse more quickly. Many things add to this risk, including living in areas with lower access to support resources and lower quality of communication and information sharing with medical team members. Over the past 18 months, our team has worked in partnership with a group of community advisory members, two who are living with chronic kidney disease, two who are care partners of someone with chronic kidney disease, and one who has experience as a social worker in a dialysis clinic. Together we have created a program focused on teaching skills for health-related decision-making. The program consists of education on 1) communication, 2) social support usefulness, or 3) a combination of both. We seek to understand how these sessions, alone or together, impact how the person with chronic kidney disease makes decisions and how they feel they receive support from their care partner and/or medical team. We also seek to understand if there are benefits to the person with chronic kidney disease and their care partner's quality of life and how the two work together to cope with the illness experience. Our goal is to positively impact health promotion by teaching answer-seeking behaviors to people with high-risk chronic kidney disease.

Our team will recruit 32 Black adults with stage 3 or 4 chronic kidney disease and one identified care partner for a total of 64 people from the University of Alabama at Birmingham (UAB) Chronic Kidney Disease Clinic and Cooper Green Primary and Kidney Specialty Care Clinic. In the study, there are four groups of participants: Group 1 will participate in one session on communication, Group 2 will receive 3 sessions on social support effectiveness; and Group 3 will have both communication and social support sessions. Group 4 will not participate in the sessions at all. All groups will be asked to complete surveys and one interview about their experience three months after the program is done. After this data collection, the participants in Group 4 will be invited to participate in the session combination they choose, so they receive potential benefit from their participation.

Participants will be paid $20 when they complete surveys at three points - 1) when starting the study, 2) at the end of three months, and 3) if the participant completes the interview. The education sessions will be delivered over video conference connection with those lacking access or the ability to connect using audio only.

We plan to share our results scientifically and in the community as a team. Our plans for community sharing is through group classes, developed from content that was shared as beneficial in the interviews at Cooper Green and the UAB Chronic Kidney Disease Clinic and in two community-based locations that the community advisory group identifies. Our team, including our community advisory croup members, will also write articles to submit to science-based journals. The results of this project will be used to prepare and submit an application to receive more funding to evaluate this program with a larger group of people from other areas in the state or the country.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 64
• Est. completion date: November 15, 2024
• Est. primary completion date: October 15, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients

1. Electronic medical record (EMR) documented diagnosis of stage 3 or 4 CKD (2 estimated glomerular filtration rate [eGFR] between 45-15 within 90 days); and concurrent cardiometabolic disease (hypertension and/or diabetes)

2. Ability to speak and read English and complete baseline questionnaires;

3. Patients must have a care partner enrolled in the study - the team will assist any patient in identifying a care partner, if interested.

Inclusion Criteria:

• Care partner

1. Age =18; 2) Self-endorsing or identified by the patient as "a relative, friend, or partner that has a close relationship with you and who assists you with your medical decisions and who may or may not live in the same residence as you and who is not paid for their help";

2. Ability to speak and read English and complete baseline questionnaires;

3. Care partners must have an enrolled patient.

Exclusion Criteria:

• Patients

1. Receiving hospice;

2. Receiving dialysis;

3. Medical record documentation of active unmedicated severe mental illness, moderate-severe dementia, suicidal ideation, uncorrected hearing loss, and active substance abuse.

Exclusion Criteria:

• Care partner 1. Self-reported unmedicated mental illness, mild-severe dementia, active suicidal ideation, uncorrected hearing loss, or active substance abuse ascertained by study introduction questioning.

Related Conditions & MeSH terms

• Cardiometabolic Risk Factors
• Kidney Diseases

Intervention

Behavioral:
• ImPart-Multi - IMproving the decisional PARTnership of Chronic Kidney Disease Dyads with concurrent metabolic disease
ImPart-Multi is a psychoeducational, decision support training program, designed to impact Black chronic kidney disease patients with concurrent metabolic disease and their care partners' ability to 1. contemplate the decision needed, 2. request resources/support, and 3. make an informed patient-centered decision. Participants will participate in either communication training, social support effectiveness training, or a combination of both.

Locations

Country	Name	City	State
United States	University of Alabama at Birmingham	Birmingham	Alabama

Sponsors (1)

Lead Sponsor	Collaborator
University of Alabama at Birmingham

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Acceptability of Intervention and Study Procedures	Through qualitative interviews, participant reported experiences with the ImPart Multi intervention and trial procedures.	Baseline to 12 weeks Groups 1, 2 and 3; 24 weeks Group 4
Primary	Feasibility of Intervention Delivery and Data Collection	Proportion of participants who complete assigned intervention group and study related assessments.	Groups 1, 2, 3 and 4 baseline through to 12 weeks; Group 4 only baseline to 24 weeks
Secondary	Decision-making process using the Decision Conflict Scale (DCS)	16 items total; measures perceptions of uncertainty in choosing options, factors contributing to uncertainty and feeling that decisions were informed and values-based	baseline, and 24 weeks after baseline
Secondary	Decision-making process using the Social Support Effectiveness-Questionnaire	25 items measuring perceptions of help received in last 3 months	baseline and 12 weeks after baseline
Secondary	Patient Wellbeing using the Kidney Disease Quality of Life Scale (KDQOL-36)	36 items measure 3 components:physical health, mental health, and kidney disease health.	baseline and 12 weeks after baseline
Secondary	Care partner well being using the PROMIS Global Health 10	10 items measure global health-related quality of life in 2 domains, physical and mental health	baseline and 12 weeks after baseline
Secondary	Dyadic Interaction using the Dyadic Coping Inventory	37 item instrument designed to measure perceived communication and dyadic coping in close relationships when one or both partners is stressed.	baseline and 12 weeks after baseline